Skip to main content
Livermore
Livermore
ZHEN

Harmony Biosciences Holdings, Inc.

HRMY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001802665

In the last 90 days, Harmony Biosciences Holdings, Inc. insiders filed 0 open-market purchases and 2 sales; 328 institutions reported holding it in 13F filings for Q2 2026, worth $1.97B in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Harmony Biosciences Holdings, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of HRMY: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders1824184+6
Shares46.1M66.5K47.7M+1.58M (+3.4%)
Value$2.26B$3.23M$2.34B+$83.1M (+3.7%)

4 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (30)

Institutions that held Harmony Biosciences Holdings, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to HRMY in Q2 2022
InstitutionSharesValue% of portfolio
Perceptive Advisors LLC411,804$20.1M0.63%
Neumeier Poma Investment Counsel LLC386,315$18.8M1.47%
Lisanti Capital Growth, LLC303,865$14.8M2.01%
Great Lakes Advisors, LLC166,338$8.11M0.16%
Ikarian Capital, LLC86,035$4.20M1.74%
Calamos Advisors LLC59,078$2.88M0.01%
Suvretta Capital Management, LLC58,734$2.86M0.11%
Altium Capital Management LP50,000$2.44M1.03%
Quantedge Capital Pte Ltd27,500$1.34M0.27%
Roman Butler Fullerton & Co16,494$885.0K0.49%
Boothbay Fund Management, LLC12,711$620.0K0.02%
Sheets Smith Investment Management11,884$559.0K0.65%
AQR Capital Management LLC10,723$523.0K0.00%
Winton Group Ltd10,707$522.0K0.03%
Raymond James & Associates6,932$338.0K0.00%
Envestnet Asset Management Inc6,531$319.0K0.00%
Rafferty Asset Management, LLC5,197$253.0K0.00%
Advisors Asset Management, Inc.4,254$207.0K0.00%
KBC Group NV2,003$98.0K0.00%
Lazard Asset Management LLC1,566$76.0K0.00%
Contravisory Investment Management, Inc.114$6.00K0.00%
Quadrant Capital Group LLC92$4.00K0.00%
Crewe Advisors LLC88$4.00K0.00%
Signaturefd, LLC70$3.00K0.00%
Rockefeller Capital Management L.P.66$3.00K0.00%
Versant Capital Management, Inc22$1.00K0.00%
Financial Synergies Wealth Advisors, Inc.5$2440.00%
Parallel Advisors, LLC7$00.00%
Lindbrook Capital, LLC5$00.00%
Steward Financial Group LLC11$00.00%

Sold out (24)

Institutions that held Harmony Biosciences Holdings, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of HRMY in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Aisling Capital Management LP342,815$16.7M
First Manhattan Co153,673$7.48M
Marshall Wace, LLP83,961$4.09M
Jump Financial, LLC51,786$2.52M
Qube Research & Technologies Ltd22,830$1.11M
Millennium Management LLC14,683$714.0K
CIBC Private Wealth Group, LLC11,434$557.0K
DuPont Capital Management Corp9,728$473.0K
FORA Capital, LLC7,562$377.0K
HSBC Holdings PLC7,290$363.0K
Bank of Montreal6,085$307.0K
Quantamental Technologies LLC6,184$301.0K
Graham Capital Management, L.P.6,166$299.0K
Point72 Hong Kong Ltd6,071$295.0K
Bayesian Capital Management, LP4,300$209.0K
BI Asset Management Fondsmaeglerselskab A/S3,798$185.0K
FNY Investment Advisers, LLC1,533$74.0K
Catalyst Capital Advisors LLC560$27.0K
Bessemer Group Inc93$5.00K
High Net Worth Advisory Group LLC100$5.00K
Kayne Anderson Rudnick Investment Management LLC33$2.00K
CWM, LLC30$1.00K
Allworth Financial LP6$0
Cordant, Inc.6$0

Not filed for Q2 2022 yet (4)

Institutions that held Harmony Biosciences Holdings, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding HRMY in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Parametric Portfolio Associates LLC48,957$2.38M
Amalgamated Financial Corp.11,150$542.0K
Teachers Retirement System of the State of Kentucky6,400$311.0K
SJS Investment Consulting Inc.1$0